A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Thumbnail
Göster/Aç
Tarih
2019
Yazar
Cekdemir, Demet
Guvenc, Serkan
Ozdemirkiran, Fusun
Eser, Ali
Topts, Tayfur
Ozkocaman, Vildan
Sahin, Handan Haydaroglu
Turak, Esra Ermis
Esen, Ramazan
Comert, Melda
Sadrilo, Sevil
Üst veri
Tüm öğe kaydını göster
Özet
Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials and Methods: A total of 285 chronic ITP patients (18
Bağlantı
https://doi.org/10.4274/tjh.galenos.2019.2018.0307
http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2336
Koleksiyonlar